Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Authors:
- Eduard MaronEMEduard Maron
- Anu TammisteATAnu Tammiste
- David J. NuttDNDavid J. Nutt
- 1 June 2009
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 19 (6) , 451-456
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorderMolecular Psychiatry, 2008
- Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?Depression and Anxiety, 2008
- Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major DepressionArchives of General Psychiatry, 2007
- Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical SampleBiological Psychiatry, 2007
- Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT studyPsychopharmacology, 2007
- Genomics and the future of pharmacotherapy in psychiatryInternational Review of Psychiatry, 2007
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderThe American Journal of Human Genetics, 2006
- Sequence Analysis of the Serotonin Transporter and Associations with Antidepressant ResponseBiological Psychiatry, 2005
- Associations between serotonin-related gene polymorphisms and panic disorderInternational Journal of Neuropsychopharmacology, 1999
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996